American Beacon Stephens Sm Cp Gr Y (SPWYX)

Fund Assets	525.41M
Expense Ratio	1.051%
Min. Investment	$100,000
Turnover	35.00%
Dividend (ttm)	n/a
Dividend Yield	n/a
Dividend Growth	n/a
Payout Frequency	Annual
Ex-Dividend Date	Dec 22, 2025

Previous Close	16.59
YTD Return	12.62%
1-Year Return	9.74%
5-Year Return	23.60%
52-Week Low	14.12
52-Week High	18.12
Beta (5Y)	1.23
Holdings	99
Inception Date	Feb 24, 2012

About SPWYX

The American Beacon Stephens Small Cap Growth Fund – Y Class is a mutual fund designed for investors seeking long-term capital appreciation by focusing on small-cap growth companies. Its primary objective is to identify and invest in businesses that demonstrate strong growth potential and are positioned at the lower end of the market-capitalization spectrum. The fund employs fundamental analysis to build a diversified portfolio and benchmarks its performance against the Russell 2000 Growth Index, which tracks fast-growing, small-cap firms across various sectors such as technology, healthcare, industrials, and consumer discretionary. Portfolio management emphasizes companies expected to outperform due to innovative products, expanding market share, or robust earnings growth. By specializing in this segment, the American Beacon Stephens Small Cap Growth Fund – Y Class offers market participants an opportunity to access the dynamic, higher-growth potential of small-cap equities, contributing to broader portfolio diversification. Its approach is particularly relevant for those aiming to capture the unique risks and rewards associated with emerging and entrepreneurial businesses within the U.S. economy.

• Fund Family: American Beacon
• Category: Small Growth
• Performance Rating: Above Average
• Risk Rating: Below Average
• Stock Exchange: Nasdaq
• Ticker Symbol: SPWYX
• Share Class: Y Class
• Index: Russell 2000 Growth TR

Performance

SPWYX had a total return of 9.74% in the past year, including dividends. Since the fund's inception, the average annual return has been 10.88%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
STSRX	R6 Class	0.96%
STSIX	R5 Class	0.99%
STSGX	Investor Class	1.27%
SPWAX	A Class	1.28%

Top 10 Holdings

18.56% of assets

Name	Symbol	Weight
Halozyme Therapeutics, Inc.	HALO	2.03%
Ligand Pharmaceuticals Incorporated	LGND	1.99%
Repligen Corporation	RGEN	1.93%
FirstCash Holdings, Inc.	FCFS	1.91%
Xometry, Inc.	XMTR	1.88%
Travere Therapeutics, Inc.	TVTX	1.84%
EZCORP, Inc.	EZPW	1.77%
Manhattan Associates, Inc.	MANH	1.76%
Twist Bioscience Corporation	TWST	1.73%
U.S. Government Money Market S	n/a	1.71%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 22, 2025	$1.3889	Dec 23, 2025
Dec 20, 2024	$0.9945	Dec 23, 2024
Dec 21, 2023	$0.1708	Dec 22, 2023
Dec 22, 2022	$1.4442	Dec 23, 2022
Dec 22, 2020	$1.9253	Dec 23, 2020
Dec 20, 2019	$1.6108	Dec 23, 2019

Data Sources: Tiingo, Financial Modeling Prep, and more

Historical data is provided by Tiingo. Delayed stock pricing data is provided by Financial Modeling Prep. Several fund data points are also provided by Finnhub.

Last checked:

Oct 16, 2026

Data Sources Report a data error